benserazide

The medicinal product is used in the treatment of Parkinson's disease. Some of its forms are also indicated for the symptomatic treatment of restless legs syndrome (RLS), including in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.

Form: capsules

ATC: N04BA02

Manufacturer: Roche Pharma AG

Madopar is used in the treatment of Parkinson's disease. Some of its formulations are also indicated for the symptomatic treatment of restless legs syndrome (RLS), including in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.

Form: capsules

ATC: N04BA02

Manufacturer: Roche Pharma AG

The medicinal product is used in the treatment of Parkinson's disease and for the symptomatic treatment of restless legs syndrome (RLS), in this case in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.

Form: suspension, oral, for preparation from tablets

ATC: N04BA02

Manufacturer: Roche Pharma AG

The medicine is used to treat Parkinson's disease, which is characterized, among other things, by slowed movements, muscle stiffness, and tremors.

Form: tablets

ATC: N04BA02

Manufacturer: ROCHE FARMA, S.A.

The medicine is used to treat Parkinson's disease, which is characterized by, among other things, slowed movements, muscle stiffness, and tremors.

Form: tablets

ATC: N04BA02

Manufacturer: Roche s.r.o.

The medicine is used to treat Parkinson's disease, which is characterized by, among other things, slowed movements, muscle stiffness, and tremors. Its purpose is to supplement the dopamine deficiency in the brain.

Form: tablets

ATC: N04BA02

Manufacturer: Roche Farma S.A.

The medicine is used to treat Parkinson's disease, which is characterized by symptoms such as muscle stiffness, tremors, and slowed movements. Its purpose is to supplement the dopamine deficiency in the brain.

Form: tablets

ATC: N04BA02

Manufacturer: Roche s.r.o.

The medicinal product is used in the treatment of Parkinson's disease and in the symptomatic treatment of restless legs syndrome (RLS), in this case in patients with renal failure requiring dialysis therapy.

Form: suspension, oral, for preparation from tablets

ATC: N04BA02

Manufacturer: Roche Pharma AG

The medicine is used to treat Parkinson's disease (manifesting as tremors, slowed movements, and muscle stiffness) and to treat symptoms resembling Parkinson's disease (parkinsonism) resulting, for example, from poisoning or brain changes caused by atherosclerosis.

Form: tablets

ATC: N04BA02

Manufacturer: Farmak International Sp. z o.o.

The medicinal product is used in the treatment of Parkinson's disease and symptoms resembling this disease (parkinsonism). It is also used in the treatment of restless legs syndrome (both of unknown cause and resulting from renal failure requiring dialysis).

Form: tablets

ATC: N04BA02

Manufacturer: Farmak International Sp. z o.o.

The medicine is used in the treatment of Parkinson's disease (manifesting as tremors, slowed movements, and muscle stiffness) and in the treatment of symptoms resembling this disease (parkinsonism). It is also used in the treatment of restless legs syndrome (both of unknown cause and resulting from renal failure requiring dialysis).

Form: tablets

ATC: N04BA02

Manufacturer: Farmak International Sp. z o.o.

Xevoben XR is used to treat Parkinson's disease and to treat restless legs syndrome (including that resulting from renal failure requiring dialysis), provided that the patient is already taking levodopa in combination with benserazide or carbidopa in an immediate-release form.

Form: capsules, extended release, hard

ATC: N04BA02

Manufacturer: Farmak International Sp. z o.o.